Financials

%ChgLast 12MReverse

	FY202312/31/2023	FY202412/31/2024	FY202512/31/2025	Last 12M03/31/2026
Cash and Cash Equivalents	16.9	8.7	21.6	14.5
Short Term Investments	-	-	-	-
Cash and Short Term Investments	16.9	8.7	21.6	14.5
Net Receivables	-	-	-	-
Inventory	-	-	-	-
Other Current Assets	0.7	0.3	0.9	1.5
Total Current Assets	19.1	10.7	23.1	16.0
Property, Plant & Equipment	5.8	4.9	4.1	3.9
Long Term Investments	-	-	-	-
Other Non-Current Assets	-	-	-	-
Total Non-Current Assets	5.8	4.9	4.1	3.9
Total Assets	24.8	15.6	27.2	19.9
Account Payables	-	3.1	0.9	0.9
Short Term Debt	-	-	0.9	0.9
Deferred Revenue	-	-	-	-
Other Current Liabilities	7.2	3.2	4.3	3.0
Total Current Liabilities	7.2	6.2	6.1	4.8
Long Term Debt	-	-	-	3.5
Other Non-Current Liabilities	-	-	-	-
Total Non-Current Liabilities	5.4	4.6	3.8	3.5
Total Liabilities	12.6	10.8	9.8	8.3
Common Stock	0.1	0.1	0.1	0.1
Retained Earnings	-223.4	-247.6	-275.1	-281.9
Total Stockholders Equity	12.2	4.8	17.4	11.6
Total Liabilities and Equity	24.8	15.6	27.2	19.9

Aptevo Therapeutics Inc.(APVO US)